United Therapeutics UTHR Peer Comparison

NASDAQ UTHR
$502.27 +4.30 (+0.86%)
As of: Sep 9, 2026 · 12:05 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

UNITED THERAPEUTICS Corp (UTHR) is the 16th largest of 300 Pharmaceuticals companies by market capitalisation, at 21.31 Bn, behind Incyte Corp at 25.36 Bn. It trades on a P/E of 16.26, broadly in line with the peer median of 16.05. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 647.54 Bn 30.78 6.61 626.78 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 441.45 Bn 69.89 6.86 434.88 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 364.78 Bn 115.11 5.48 357.64 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 267.01 Bn 9.27 3.89 259.32 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 158.95 Bn 36.39 2.50 147.25 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 52.54 Bn 11.27 0.98 45.16 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 44.23 Bn -25.01 — 44.23 Bn
8 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.36 Bn 15.73 4.36 20.82 Bn
9 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 21.31 Bn 16.26 6.76 18.65 Bn
10 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.53 Bn 22.02 4.60 15.15 Bn
11 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.13 Bn 16.08 3.29 13.51 Bn
12 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.41 Bn 16.75 5.92 13.57 Bn
13 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 12.29 Bn 226.82 14.80 11.99 Bn
14 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 11.40 Bn -38.04 108.54 10.71 Bn
15 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.88 Bn -70.79 14.01 10.56 Bn
16 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
17 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 9.74 Bn -13.28 143.91 8.57 Bn
18 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.41 Bn -50.01 — 9.41 Bn
19 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
20 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.59 Bn 114.81 4.55 6.94 Bn
21 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 6.21 Bn 0.08 — 6.21 Bn
22 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.18 Bn -142.29 10.46 6.07 Bn
23 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 43.92 13.50 5.80 Bn
24 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -219.55 31.98 5.64 Bn
25 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.78 Bn 12.55 4.19 3.82 Bn
26 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.66 Bn -23.64 — 4.66 Bn
27 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.20 Bn -11.88 — 4.20 Bn
28 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.05 Bn 11.41 3.04 3.83 Bn
29 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -46.57 — 4.01 Bn
30 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
31 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -45.72 — 3.85 Bn
32 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -78.05 6.04 3.21 Bn
33 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.61 Bn 17.26 0.59 2.47 Bn
34 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -11.17 407.13 2.90 Bn
35 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -7.51 — 2.62 Bn
36 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 4.56 0.06 -3.18 Bn
37 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn -61.82 — 2.61 Bn
38 BEIGF BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
39 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.61 3.09 2.06 Bn
40 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 13.64 2.53 1.63 Bn
41 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -21.22 13.51 2.29 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -41.35 — 1.88 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.67 6.73 1.65 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.64 Bn 171.80 16.36 1.61 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.54 Bn 7.84 2.99 0.96 Bn
46 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -24.09 — 1.46 Bn
47 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -84.47 4.32 1.33 Bn
48 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.26 5.13 1.33 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -31.29 2.02 0.88 Bn
50 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -5.42 — 1.11 Bn
51 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.53 13.97 1.08 Bn
52 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 69.00 1.35 0.76 Bn
53 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -15.13 22.94 0.76 Bn
54 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.76 — 0.74 Bn
55 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -48.72 — 0.93 Bn
56 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.20 0.67 Bn
57 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 16.02 0.95 0.62 Bn
58 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.56 3.10 0.56 Bn
59 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.55 5.37 0.51 Bn
60 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -38.37 5.93 0.65 Bn
61 IVEVF Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
62 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.09 1.71 0.38 Bn
63 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -8.18 11.83 0.54 Bn
64 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -3.07 — 0.62 Bn
65 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -16.63 1.80 0.53 Bn
66 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -18.13 — 0.55 Bn
67 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.46 336.78 0.42 Bn
68 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.37 4.48 0.38 Bn
69 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.61 889.92 0.32 Bn
70 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.91 27.94 0.25 Bn
71 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -6.46 — 0.26 Bn
72 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -53.83 — 0.41 Bn
73 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -85.61 11.05 0.41 Bn
74 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -3.42 — 0.33 Bn
75 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn — — 0.33 Bn
76 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.15 1.46 0.15 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.12 — 0.30 Bn
78 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -1.66 0.38 0.15 Bn
79 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.25 — 0.29 Bn
80 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.97 — 0.28 Bn
81 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.88 1.20 0.11 Bn
82 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.02 0.00 -10.84 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn — — 0.07 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.35 7.42 0.22 Bn
85 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -57.60 3.09 0.18 Bn
86 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.78 — 0.20 Bn
87 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.30 14.98 0.16 Bn
88 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -30.08 — 0.20 Bn
89 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.47 107.94 0.15 Bn
90 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -37.45 8.18 0.19 Bn
91 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.52 — 0.13 Bn
92 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -46.69 — 0.16 Bn
93 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.24 7.47 0.16 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.37 — 0.13 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.27 — 0.10 Bn
96 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.44 3.57 0.10 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.54 — 0.03 Bn
98 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -8.98 3.10 0.09 Bn
99 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.48 — 0.10 Bn
100 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.50 — 0.09 Bn
101 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.04 — 0.09 Bn
102 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -7.59 99.85 0.09 Bn
103 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -0.76 1.57 0.06 Bn
104 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
105 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.21 — -0.01 Bn
106 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.77 — 0.07 Bn
107 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
108 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 117.37 — 0.03 Bn
109 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.30 0.96 -0.01 Bn
110 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.25 0.33 -0.02 Bn
111 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.96 — 0.05 Bn
112 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.34 213.14 0.04 Bn
113 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.42 — 0.04 Bn
114 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.85 — 0.04 Bn
115 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.18 -0.08 Bn
116 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.85 — 0.04 Bn
117 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.57 8.66 0.03 Bn
118 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.56 2.94 0.02 Bn
119 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.54 — 0.03 Bn
120 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
121 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.02 — 0.03 Bn
122 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.84 76.69 0.03 Bn
123 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -135.76 7.68 0.02 Bn
124 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.12 46.85 0.00 Bn
125 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 0.40 0.00 Bn
126 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.72 — 0.02 Bn
127 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.68 814.63 0.02 Bn
128 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.31 0.45 0.02 Bn
129 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.56 — 0.01 Bn
130 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.68 — 0.02 Bn
131 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.42 — 0.02 Bn
132 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.34 2.18 0.02 Bn
133 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.64 — 0.01 Bn
134 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.67 — 0.01 Bn
135 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.32 -8.02 -0.01 Bn
136 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.74 — 0.01 Bn
137 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.88 — 0.00 Bn
138 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
139 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
140 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.46 — 0.01 Bn
141 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.34 — 0.00 Bn
142 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.41 — 0.01 Bn
143 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.94 1,276.64 0.00 Bn
144 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
145 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.29 — 0.00 Bn
146 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
147 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.23 — 0.00 Bn
148 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
149 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.24 5.93 0.00 Bn
150 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
151 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
152 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.05 54.04 0.00 Bn
153 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
154 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
155 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
156 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
157 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.01 -0.01 Bn
158 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
159 CINGW Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 181.55 Bn -62.71 5.96 178.37 Bn
163 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.31 Bn 30.03 10.51 124.45 Bn
164 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.93 Bn 61.68 2.48 39.28 Bn
165 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 33.97 Bn 52.83 3.16 32.51 Bn
166 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.10 Bn -20.28 2,755.62 30.10 Bn
167 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.92 Bn 14.59 1.41 27.81 Bn
168 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.83 Bn -31.80 24.46 26.67 Bn
169 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.25 Bn -46.86 1.31 18.36 Bn
170 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.48 Bn 40.67 4.12 13.88 Bn
171 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.52 Bn 171.54 3.67 11.64 Bn
172 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.68 Bn -67.82 17.43 10.57 Bn
173 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.20 Bn -26.74 — 9.44 Bn
174 KRYS Krystal Biotech, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 10.13 Bn 41.97 23.00 9.29 Bn
175 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.46 Bn -8.52 51.02 8.10 Bn
176 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 17.57 9.71 7.08 Bn
177 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.43 Bn -39.46 1.21 6.05 Bn
178 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -703.30 4,524.98 6.30 Bn
179 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.52 Bn 25.65 1.77 5.39 Bn
180 CRSP CRISPR Therapeutics AG secondary H-03 Pharmaceuticals and Biotechnology HG-01 5.15 Bn -10.65 384.77 5.15 Bn
181 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.55 — 5.04 Bn
182 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
183 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.86 1,115.68 4.02 Bn
184 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -18.46 11.87 3.56 Bn
185 LEGN Legend Biotech Corp secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.65 Bn -173.14 2.87 2.68 Bn
186 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.58 Bn -7.79 30.62 2.88 Bn
187 QURE uniQure N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.05 Bn -15.51 163.36 3.05 Bn
188 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -11.06 593.06 2.47 Bn
189 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -8.55 79.36 2.47 Bn
190 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -15.03 6.29 2.12 Bn
191 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.72 Bn -22.95 2.08 2.63 Bn
192 BEAM Beam Therapeutics Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.63 Bn -30.79 16.86 2.63 Bn
193 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.63 Bn -81.01 — 2.63 Bn
194 PGEN Precigen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -7.13 28.00 2.40 Bn
195 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2.18 0.22 0.55 Bn
196 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.35 Bn -17.11 1.19 1.55 Bn
197 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.31 Bn -5.99 4.31 1.95 Bn
198 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -3.84 — 1.99 Bn
199 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -4.92 2,045.15 2.05 Bn
200 VCEL Vericel Corp secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.98 Bn 79.10 6.48 1.82 Bn
201 TSHA Taysha Gene Therapies, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -13.13 358.28 1.97 Bn
202 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
203 NTLA Intellia Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -4.09 27.43 1.63 Bn
204 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
205 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 13.88 1.53 1.14 Bn
206 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -3.23 2.08 1.20 Bn
207 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.68 — 1.42 Bn
208 SLDB Solid Biosciences Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -6.85 — 1.40 Bn
209 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
210 MGTX MeiraGTx Holdings plc secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.23 Bn 7.47 3.08 1.09 Bn
211 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -25.48 — 1.00 Bn
212 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -4.72 23.40 0.68 Bn
213 FDMT 4D Molecular Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -5.57 10.85 0.64 Bn
214 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -69.78 — 0.91 Bn
215 SANA Sana Biotechnology, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -4.41 — 0.94 Bn
216 CADL Candel Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -14.01 — 0.92 Bn
217 NGNE Neurogene Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -7.76 — 0.87 Bn
218 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -10.51 101.77 0.84 Bn
219 IMMX Immix Biopharma, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -25.88 — 0.82 Bn
220 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -344,077.60 — 0.60 Bn
221 PRME Prime Medicine, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.18 146.64 0.60 Bn
222 ALLO Allogene Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -3.53 126.18 0.59 Bn
223 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.58 Bn 1,174.84 6.08 0.48 Bn
224 BNTC Benitec Biopharma Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -12.35 — 0.57 Bn
225 AUTL Autolus Therapeutics plc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -2.14 4.90 0.35 Bn
226 IRD Opus Genetics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -5.57 54.98 0.45 Bn
227 CAPR Capricor Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.12 — 0.52 Bn
228 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -7.58 22.77 0.23 Bn
229 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
230 KYTX Kyverna Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -3.08 — 0.47 Bn
231 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.80 — 0.45 Bn
232 CABA Cabaletta Bio, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -2.53 — 0.46 Bn
233 RGNX REGENXBIO Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -2.58 2.41 0.35 Bn
234 ARTV Artiva Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -4.72 — 0.43 Bn
235 IPSC Century Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.83 — 0.16 Bn
236 RCKT Rocket Pharmaceuticals, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -23.81 — 0.41 Bn
237 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.26 40.29 0.20 Bn
238 LXEO Lexeo Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.48 — 0.39 Bn
239 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.68 83.56 0.28 Bn
240 PROK Prokidney Corp. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -2.60 424.44 0.35 Bn
241 ABEO Abeona Therapeutics Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -3.02 12.80 0.18 Bn
242 SWKHL SWK Holdings Corp secondary F-06 Lending and Credit FG-02 0.31 Bn -332.76 7.48 0.27 Bn
243 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.42 5.23 0.14 Bn
244 LYEL Lyell Immunopharma, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.25 11,387.79 0.31 Bn
245 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 3.22 2.23 0.30 Bn
246 FATE Fate Therapeutics Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.35 45.44 0.29 Bn
247 NWBO Northwest Biotherapeutics Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -7.16 128.04 0.28 Bn
248 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -2.98 18.85 0.09 Bn
249 LCTX Lineage Cell Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -11.32 19.83 0.20 Bn
250 RNAC Cartesian Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.34 171.78 0.25 Bn
251 EDIT Editas Medicine, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.25 Bn — — 0.11 Bn
252 MEOBF Mesoblast Ltd secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -4.28 2.05 0.14 Bn
253 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.37 — 0.24 Bn
254 NKTX Nkarta, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -1.59 — 0.23 Bn
255 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.09 — 0.21 Bn
256 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.37 5.65 0.08 Bn
257 DTIL Precision Biosciences Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -5.59 4.21 0.10 Bn
258 ZSQR Z Squared Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -8.13 56.04 0.14 Bn
259 ATRA Atara Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.51 24.73 0.14 Bn
260 CRBU Caribou Biosciences, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.36 14.84 0.04 Bn
261 TNYA Tenaya Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.42 109.36 0.15 Bn
262 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,818.12 -0.04 Bn
263 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.88 — 0.14 Bn
264 HUMA Humacyte, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.14 64.20 0.14 Bn
265 ENGN enGene Therapeutics Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.02 — 0.13 Bn
266 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.32 — 0.13 Bn
267 GUTS Fractyl Health, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.11 Bn -0.85 — 0.11 Bn
268 ACET Adicet Bio, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.03 — -0.02 Bn
269 PLYX Polaryx Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.86 — 0.09 Bn
270 ANIX Anixa Biosciences Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.21 — 0.10 Bn
271 PYPD PolyPid Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 2.70 — 0.08 Bn
272 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 10.00 1.21 -0.11 Bn
273 AIFC AI Financial Corp secondary T-54 Fintech TG-09 0.07 Bn -0.08 3.44 0.06 Bn
274 INMB Inmune Bio, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.35 — 0.05 Bn
275 INKT MiNK Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -5.16 — 0.06 Bn
276 APTN Adaptin Bio, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -10.22 — 0.06 Bn
277 PTN Palatin Technologies Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.83 3.81 0.05 Bn
278 MGX Metagenomi Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 2.02 0.04 Bn
279 SGMOQ Sangamo Therapeutics, Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.36 1.11 0.02 Bn
280 TCRX TScan Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.37 6.06 0.04 Bn
281 SER Serina Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.48 321.52 0.02 Bn
282 ATNM Actinium Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.48 1.12 0.04 Bn
283 CELU Celularity Inc secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.42 1.44 0.03 Bn
284 APLM Apollomics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.03 Bn
285 BETRF BetterLife Pharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
286 KAPA Kairos Pharma, LTD. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
287 ESLA Estrella Immunopharma, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.93 — 0.03 Bn
288 TVGN Tevogen Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 — 0.03 Bn
289 MRKR Marker Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.38 — 0.01 Bn
290 INAB In8Bio, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.20 — 0.02 Bn
291 LGVN Longeveron Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.88 17.45 0.01 Bn
292 GNTA Genenta Science S.p.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.87 — 0.02 Bn
293 MDBH MDB Capital Holdings, LLC secondary F-17 Capital Markets FG-05 0.02 Bn -1.26 — 0.01 Bn
294 PASG Passage BIO, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.38 — 0.01 Bn
295 QCLS Q/C Technologies, Inc. secondary T-01 Semiconductors TG-01 0.01 Bn -2.05 — 0.01 Bn
296 RKTO Rocket One Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.04 — 0.01 Bn
297 ADIA Adia Nutrition, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -75.51 69.62 0.01 Bn
298 PLUR Pluri Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.00 8.64 0.00 Bn
299 FBLG FibroBiologics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.65 — 0.01 Bn
300 GDTC CytoMed Therapeutics Ltd secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.25 40.49 0.01 Bn